Anti-Human IFNG Recombinant Antibody (Fontolizumab)

CAT#: TAB-041

Recombinant monoclonal antibody to IFNG. Fontolizumab (planned trade name HuZAF) is a humanized monoclonal antibody and an immunosuppressive drug for the treatment of auto-immune diseases like Crohn's disease.

Published Data Tested Data Gene Expression
Figure 1 Mean (SEM) Crohn’s disease activity index (CDAI) for patients receiving two doses of study drug.
Figure 1 Anti-Human IFNG Recombinant Antibody (TAB-041) in SDS-PAGE Figure 2 Anti-Human IFNG Recombinant Antibody (TAB-041) in HPLC
Figure 1 Colon Figure 2 RNA cell line category: Not detected

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Mouse
  • Derivation
  • Humanized (from mouse)
  • Type
  • IgG1
  • Specificity
  • Tested positive against native human antigen.
  • Species Reactivity
  • Human
  • Applications
  • IP, IF, FuncS, FC, Neut, ELISA, IHC, Activ
  • Trade name
  • huzaf
  • CAS
  • 326859-36-3
  • Generic Name
  • Fontolizumab
  • UNII
  • 6J92H2439Z
  • MW
  • 150 kDa
  • Related Disease
  • Crohn's disease (CD)

Product Property

  • Purity
  • >95.0%, determined by analysis by RP-HPLC & analysis by SDS-PAGE.
  • Storage
  • Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples.

Applications

  • Application Notes
  • The IFNG antibody has been reported in applications of IP, IF, FuncS, FC, Neut, ELISA, IHC, Activ.

Target

  • Alternative Names
  • Fontolizumab;huzaf;326859-36-3;HuZAF;flintozumab;IFNG;interferon, gamma;interferon gamma;IFN-gamma;immune interferon;IFG;IFI;
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for TAB-041. Click the button above to contact us or submit your feedback about this product.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Biosimilar Overview

Please refer to Fontolizumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Fontolizumab.

Related Diseases

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

Protocol & Troubleshooting

We have outlined the assay protocols, covering reagents, solutions, procedures, and troubleshooting tips for common issues in order to better assist clients in conducting experiments with our products. View the full list of Protocol & Troubleshooting.

See other products for "Fontolizumab"

Afuco™ Anti-IFNG ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-041)
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to IFNG. It is a humanized monoclonal antibody and an immunosuppressive drug for the treatment of auto-immune diseases like Crohn's disease.
DrugMonitor™ Anti-Fontolizumab Antibody (VS-1224-YC486)
Fontolizumab is a humanized monoclonal antibody used as an immunosuppressive drug to treat Crohn's disease. The DrugMonitor™ Anti-Fontolizumab Antibody (VS-1224-YC486) is an anti-drug antibody (ADA) against Fontolizumab. This drug-based antibody is raised in mice immunized with the Fontolizumab. The anti-Fontolizumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Fontolizumab in samples.

See other products for "IFNG"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
MOB-0289MC Recombinant Anti-Canine IFN-gamma Antibody. WB, ELISA
CAT Product Name Application Type
EPAF-0882LC Mouse Anti-IFNG Recombinant Antibody (clone MIF3009) ELISA Mouse IgG1
CAT Product Name Application Type
AFC-TAB-041 Afuco™ Anti-IFNG ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-041) IP, IF, FuncS, FC, Neut, ELISA ADCC enhanced antibody
AFC-TAB-423CQ Afuco™ Anti-IFNG ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-423CQ) ELISA, IHC, FC, IP, IF, FuncS ADCC enhanced antibody
CAT Product Name Application Type
VS-0424-XY143 AbPlus™ Anti-IFNG Magnetic Beads (B27) IP, Protein Purification
CAT Product Name Application Type
VS-1024-XY270 Mouse Anti-NHP IFNG Recombinant Antibody (VS-1024-XY270) FC Mouse IgG1, kappa
CAT Product Name Application Type
VS-0425-FY40 Human Anti-IFNG (clone BS-A) scFv-Fc Chimera Neut, ELISA Human IgG1, scFv-Fc
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare